Jason P.W. Carey

883 total citations
13 papers, 582 citations indexed

About

Jason P.W. Carey is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jason P.W. Carey has authored 13 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jason P.W. Carey's work include Cancer-related Molecular Pathways (5 papers), Cancer-related gene regulation (4 papers) and Advanced Breast Cancer Therapies (3 papers). Jason P.W. Carey is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Cancer-related gene regulation (4 papers) and Advanced Breast Cancer Therapies (3 papers). Jason P.W. Carey collaborates with scholars based in United States, United Kingdom and Germany. Jason P.W. Carey's co-authors include Jaideep Chaudhary, Khandan Keyomarsi, Kelly K. Hunt, Ananthi J. Asirvatham, Tuyen Bui, Smruthi Vijayaraghavan, Cansu Karakaş, Divya Patel, Oliver Galm and Derrick J. Morton and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Jason P.W. Carey

13 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason P.W. Carey United States 12 386 307 111 101 63 13 582
Ademi Santiago-Walker United States 13 402 1.0× 271 0.9× 99 0.9× 190 1.9× 70 1.1× 26 682
Roza Zandi Denmark 7 324 0.8× 264 0.9× 91 0.8× 103 1.0× 37 0.6× 9 540
Prasad Chaskar Switzerland 6 372 1.0× 387 1.3× 63 0.6× 187 1.9× 40 0.6× 8 600
Christopher R. Shepard United States 4 412 1.1× 411 1.3× 112 1.0× 190 1.9× 67 1.1× 4 735
Salvatore A. Del Prete United States 10 307 0.8× 374 1.2× 99 0.9× 154 1.5× 99 1.6× 13 665
Shailaja Uttamsingh United States 11 418 1.1× 291 0.9× 87 0.8× 97 1.0× 40 0.6× 18 622
Takashi Kurizaki Japan 14 307 0.8× 230 0.7× 69 0.6× 153 1.5× 62 1.0× 25 550
Erwin Tomasich Austria 13 336 0.9× 179 0.6× 120 1.1× 187 1.9× 72 1.1× 31 547
Mariam Gachechiladze Czechia 11 255 0.7× 207 0.7× 81 0.7× 81 0.8× 66 1.0× 30 486
Raquel Batlle Spain 7 345 0.9× 227 0.7× 56 0.5× 190 1.9× 87 1.4× 7 552

Countries citing papers authored by Jason P.W. Carey

Since Specialization
Citations

This map shows the geographic impact of Jason P.W. Carey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason P.W. Carey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason P.W. Carey more than expected).

Fields of papers citing papers by Jason P.W. Carey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason P.W. Carey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason P.W. Carey. The network helps show where Jason P.W. Carey may publish in the future.

Co-authorship network of co-authors of Jason P.W. Carey

This figure shows the co-authorship network connecting the top 25 collaborators of Jason P.W. Carey. A scholar is included among the top collaborators of Jason P.W. Carey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason P.W. Carey. Jason P.W. Carey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Chen, Xian, Angela Alexander, Yufeng Jiang, et al.. (2018). Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition. Clinical Cancer Research. 24(24). 6594–6610. 78 indexed citations
3.
Duong, MyLinh, et al.. (2018). Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies. Cancer Research. 78(19). 5481–5491. 51 indexed citations
4.
Carey, Jason P.W., Cansu Karakaş, Tuyen Bui, et al.. (2017). Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer. Cancer Research. 78(3). 742–757. 103 indexed citations
5.
Vijayaraghavan, Smruthi, Iman Doostan, Jason P.W. Carey, & Khandan Keyomarsi. (2017). Abstract 2060: Characterizing acquired resistance to palbociclib in breast cancer. Cancer Research. 77(13_Supplement). 2060–2060. 6 indexed citations
6.
Alexander, Angela, Cansu Karakaş, Xian Chen, et al.. (2017). Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer. Oncotarget. 8(9). 14897–14911. 42 indexed citations
7.
Balaji, Kavitha, Smruthi Vijayaraghavan, Lixia Diao, et al.. (2016). AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers. Molecular Cancer Research. 15(1). 45–58. 70 indexed citations
8.
Bui, Tuyen, Cansu Karakaş, Jason P.W. Carey, et al.. (2015). PKCiota promotes ovarian tumor progression through deregulation of cyclin E. Oncogene. 35(19). 2428–2440. 17 indexed citations
9.
Patel, Divya, et al.. (2014). Inhibitor of differentiation 4 (ID4): From development to cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1855(1). 92–103. 55 indexed citations
10.
Carey, Jason P.W., et al.. (2013). Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells.. PubMed. 33(10). 4271–8. 18 indexed citations
11.
Sharma, Pankaj, et al.. (2012). Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer. Cancer Medicine. 1(2). 176–186. 22 indexed citations
12.
Carey, Jason P.W., et al.. (2009). Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer. BMC Cancer. 9(1). 173–173. 57 indexed citations
13.
Asirvatham, Ananthi J., Jason P.W. Carey, & Jaideep Chaudhary. (2007). ID1‐, ID2‐, and ID3‐regulated gene expression in E2A positive or negative prostate cancer cells. The Prostate. 67(13). 1411–1420. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026